Abstract Submission

ABSTRACT SUBMISSION GUIDELINES

Each abstract submitter is required to pay the abstract submission fee of 20€. The payment must be completed through the same submission platform.

All abstracts must be written in English.
Abstracts must be submitted exclusively through the official online abstract submission system:

Abstracts submitted via e-mail or any other channel will not be considered for evaluation.
Submission deadline: May 1, 2026 – 23:59 (CET / Madrid time).
Submissions received after this time will not be accepted by the system.
Please do not submit multiple copies of the same abstract.
Acronyms should be used only when strictly necessary. All non-standard abbreviations must be defined at first use.
Submitting authors are responsible for ensuring that all co-authors have reviewed and approved the abstract prior to submission.
Authors must carefully review their abstracts before final submission. Any spelling, grammatical, or scientific inaccuracies will be reproduced exactly as entered.
Immediately after submission, a confirmation e-mail will be automatically generated by the system. If the confirmation message is not received, authors are advised to check their spam or junk mail folder.
All official correspondence regarding the abstract, including review outcomes and presentation scheduling, will be conducted exclusively through the presenting author.
Abstract submission is considered complete only after successful payment.
Only accepted abstracts whose presenting authors have completed conference registration before July 1, 2026 will be included in the Scientific Program and official conference publications.

ABSTRACT PREPARATION AND SUBMISSION

STEP 1 – Presentation Preference

Authors must select one of the following presentation formats:

Oral Presentation
Poster Presentation

The Scientific Committee reserves the right to assign the final presentation format in accordance with program requirements. All decisions are final.

STEP 2 – PRESENTING AUTHOR

The presenting author must be designated at this step.

This designation is of critical importance, as all abstract-related communications will be sent exclusively to the presenting author. Authors are responsible for ensuring that the contact details provided are accurate and active.

STEP 3 – INSTITUTION INFORMATION

Affiliations must be provided for each author.

Each affiliation must be indicated in full and include:

Department
Institution
City
Country

Institutional names must not be abbreviated (e.g., Dept., Univ., Hosp., Inst.).

Each affiliation should be entered only once and correctly assigned to the corresponding authors.

STEP 4 – AUTHOR INFORMATION

All authors’ names (first, middle, last) must be entered accurately and in the correct order.

Affiliations must be correctly matched to each author.

Authors are responsible for verifying the accuracy of author details and order prior to submission.

STEP 5 – ABSTRACT TITLE

Abstract titles must:

Clearly reflect the study content
Contain no abbreviations
Not exceed 100 characters
Avoid full capitalization

Only generic drug names may be used. Brand or commercial names are not permitted.

STEP 6 – ABSTRACT BODY

The abstract body must not exceed 2500 characters.

The abstract must follow the structured format below:

Objectives – Clearly state the purpose of the study
Methods – Describe study design and methodology
Results – Present findings with sufficient detail
Conclusions – Summarize implications and significance

The abstract must not include:

References
Funding sources
Acknowledgements
Identifiable patient information

Statements such as “results will be discussed” or “data will be presented” are not acceptable.

STEP 7 – KEYWORDS

Minimum: 1 keyword
Maximum: 6 keywords
All keywords must be written in lower case

Keywords must be entered only in the designated field and not within the abstract body.

STEP 8 – ADDITIONAL FILES

Figures, tables, and images may be uploaded where applicable.

Authors are responsible for ensuring that uploaded materials are accurate and correspond to the submitted abstract.

STEP 9 – REVIEW & VERIFICATION

Authors are strongly encouraged to review all entered information prior to final submission.

The accuracy of the submitted content remains the sole responsibility of the authors.

STEP 10 – FINAL SUBMISSION & PAYMENT

Submission will only be completed once all required fields have been filled.

The payment process is completed through the same platform.

Abstract submission is considered complete only after successful payment.

AFTER SUBMISSION

A system-generated confirmation e-mail will be sent immediately after submission.

Authors who do not receive this notification should check their spam or junk mail folder.

Only fully submitted abstracts will proceed to the review process.

REVIEW PROCESS

All submitted abstracts will undergo scientific evaluation after the submission deadline.

Notification of acceptance decisions will be communicated via e-mail to the presenting author.

REGISTRATION REQUIREMENTS FOR PRESENTERS

Presenting authors of accepted abstracts must complete conference registration before July 1, 2026.

Accepted abstracts associated with unregistered presenters may be removed from the Scientific Program and conference materials.

For further inquiries, please contact:

sparrot@globalproevents.com

On behalf of the Organizing Committee of the 10th World Intracranial Hemorrhage Conference, we would like to thank you for submitting your work as an abstract.

The online submission and evaluation process is administered by Global Proevent, the Conference Organizing Secretariat.

Abstract Submission Deadline is May 1, 2026 23:59 (CET).

Registration will be opening in the coming days

Each abstract submitter should pay the abstract submission fee of 20€ to

be able to submit and that the abstract will be sent to review. Please

pay HERE

On behalf of the Organizing Committee of the 10th World Intracranial Hemorrhage Conference, we would like to thank you for submitting your work as an abstract.

The online submission and evaluation process is administered by Global Proevent, the Conference Organizing Secretariat.

Abstract Submission Deadline is May 1, 2026 23:59 (CET).

Registration will be opening in the coming days

Each abstract submitter should pay the abstract submission fee of 20€ to be able to submit and that the abstract will be sent to review.

Please take a moment to read the below guidelines before submitting your abstract:

ABSTRACT SUBMISSION GUIDELINE

Each abstract submitter should pay the abstract submission fee of 20€ to be able to submit and that the abstract will be sent to review.
All abstracts must be written in English.
All abstracts must be submitted online through the abstract submission system by the deadline given above. Abstracts that are sent via e-mail will not be included in the abstract review process.
Please do NOT submit multiple copies of the same abstract.
Use acronyms only when necessary and define all abbreviations and concepts in your abstract at first use.
The submitting and presenting authors are required to ensure that all co-authors are aware of the content of the abstract before submission.
Always make sure to check the final abstract with the system’s preview function before submission and edit or replace as necessary. It is the authors’ responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
Only the accepted abstracts of presenting authors who have completed their registrations and paid their registration fees by the abstract presenters registration deadline July 1, 2026 will be included in the Scientific Program, conference abstract e-book and Cerebrovascular Diseases journal.

ABSTRACT PREPARATION AND SUBMISSION ON THE SYSTEM

STEP 1- Presentation Preference

Presentation type: Please choose one of the following:
– Oral presentation
– Poster presentation
The Scientific Committee reserves the right to change the presentation type according to the requirements of the scientific program. The decision of the Committee is final.

STEP 2 – Institution Information

The institution(s) of the authors should be indicated fully with the “department” and “institution” names while avoiding any abbreviations such as Dept., Univ., Inst., Hosp., etc.
The department and institution details, city and country should be written with lower case while the initials of each word in capitals.
Please make sure to include the City and Country information at the end for each institution.
Enter each affiliation only once.

STEP 3 – Author Information

First, middle and last names of all the authors must be fully indicated correctly and in the right order. Please pay attention to matching the institutions from the dropdown menu to the right authors, and make sure that you select the “presenting author” correctly from the Author List.

STEP 4 – Presenting Author Information

Please enter the presenting author’s contact information correctly.
It’s highly important for you to ensure that the e-mail address of presenting author is entered correctly, as all communication regarding the acceptance, any required adjustments, and scheduling will be sent to the presenting author via e-mail by the Conference Organizing Secretariat.

STEP 5 – Abstract Title

An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
Abstract titles can contain a maximum of 100 characters.
Titles should not be written with all capitals.
Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. WICH 2026 Organizing and Scientific Committees reserve the right to replace any brand name with a generic name.

STEP 6 – Abstract

Abstract Body: Abstract body should not exceed 2500 characters. The title of the abstract, authors, institutions and keywords are not included in this limit, and those should not be entered in this section.
Abstract body should consist of 4 sections given below:
– Objectives: Clearly state the purpose of the abstract. Briefly describe the objectives of the study unless they are contained in the title.
– Methods: Describe your selection of observations or experimental subjects clearly. Include a brief statement of methods if pertinent.
– Results: Present your results in a logical sequence in text, table and illustrations. State findings in sufficient detail to support conclusions.
– Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
Standard abbreviations may be used without definition. Non-standard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
Do not include the names or personal information of any patient participating in a study or trial.
Phrases such as “results will be discussed” or “data will be presented” shall not be used.
References, funding sources and acknowledgements should not be included in the abstract body.

STEP 7 – Keywords

Keywords should not be included in the abstract body but written in the section dedicated for keywords.
Minimum 1 keyword is required and maximum 6 keywords can be entered.
All keywords should be written in lower case. Type the keyword in the ‘Select or type tags’ field and press enter.

STEP 8 – Additional Files

Images, tables, diagrams and graphs are accepted.

STEP 9 – Preview & Check

Any comments and/or additional information to be shared with the Scientific Committee can be submitted through the comment box.

STEP 10 – Submit to the Committee

If you have not completed all required sections of your abstract, you won’t see the submission button. Only after completing all required fields, the submission button will be enabled for you.

After Submission

When the submission process is finalized, you will see your abstract on your account Home page. Please be aware that the Scientific Committee will not receive “Not-Submitted Abstracts” and these therefore CANNOT be taken into consideration in the abstract review process.
Upon submitting of your abstract an e-mail including the “Abstract Number” and “Abstract Title” will be sent to the submitting author. Please make sure to save your username and password for future use.

REVIEW PROCESS AND ACCEPTANCE LETTERS

All submitted abstracts will be scored and passed through a review process after the submission closes. The notification letters about acceptance of the abstracts will be sent.

REGISTRATION OF ABSTRACT PRESENTERS

The presenting author(s) must be registered for the Conference latest by July 1, 2026, which is the registration deadline for abstract presenters.

The abstracts of unregistered presenting authors who do not complete registration (including payment) by this deadline will be removed from the final program, all conference publications and Cerebrovascular Diseases journal.

***

Thank you for submitting your work for consideration. Please contact us directly at sparrot@globalproevents.com, should you have any specific inquiries.

#WICH2026

JOIN WICH

Abstract Submission

Abstract Submission